Alpha One Foundation
Lobbying activity
The following activities occurred for this specific Subject Matter Area.
Email (21-30)
Emailed TD's and Senators in relation to access of new therapies (RESPREEZA) for Alpha-1 Antitrypsin Deficiency patients.
Email (21-30)
Emailed TD's and Senators in relation to an AV room briefing in Leinster House on 12th April 2017
Letter (21-30)
Letters sent to Minsters and member of the Oireachtas Health Committee and the Health Service Executive (HSE) in relation to access of new therapies ( RESPREEZA) for Alpha-1 Antitrypsin Deficiency patients.
Designated public officials lobbied
The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.